179 related articles for article (PubMed ID: 31319019)
21. Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening.
Bettiol E; Samanovic M; Murkin AS; Raper J; Buckner F; Rodriguez A
PLoS Negl Trop Dis; 2009; 3(2):e384. PubMed ID: 19238193
[TBL] [Abstract][Full Text] [Related]
22. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
[TBL] [Abstract][Full Text] [Related]
23. New benzimidazolequinones as trypanosomicidal agents.
López-Lira C; Tapia RA; Herrera A; Lapier M; Maya JD; Soto-Delgado J; Oliver AG; Graham Lappin A; Uriarte E
Bioorg Chem; 2021 Jun; 111():104823. PubMed ID: 33798844
[TBL] [Abstract][Full Text] [Related]
24. New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms.
Carneiro PF; do Nascimento SB; Pinto AV; Pinto Mdo C; Lechuga GC; Santos DO; dos Santos Júnior HM; Resende JA; Bourguignon SC; Ferreira VF
Bioorg Med Chem; 2012 Aug; 20(16):4995-5000. PubMed ID: 22795899
[TBL] [Abstract][Full Text] [Related]
25. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.
Moreno-Viguri E; Jiménez-Montes C; Martín-Escolano R; Santivañez-Veliz M; Martin-Montes A; Azqueta A; Jimenez-Lopez M; Zamora Ledesma S; Cirauqui N; López de Ceráin A; Marín C; Sánchez-Moreno M; Pérez-Silanes S
J Med Chem; 2016 Dec; 59(24):10929-10945. PubMed ID: 28002965
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.
Hartmann AP; de Carvalho MR; Bernardes LSC; Moraes MH; de Melo EB; Lopes CD; Steindel M; da Silva JS; Carvalho I
Eur J Med Chem; 2017 Nov; 140():187-199. PubMed ID: 28926763
[TBL] [Abstract][Full Text] [Related]
27. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
[TBL] [Abstract][Full Text] [Related]
28. Structure Activity Relationship of
Sijm M; Maes L; de Esch IJP; Caljon G; Sterk GJ; Leurs R
Front Chem; 2021; 9():608438. PubMed ID: 33996737
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anti-Trypanosoma cruzi activity of diaryldiazepines.
Menezes JC; Vaz LB; de Abreu Vieira PM; da Silva Fonseca K; Carneiro CM; Taylor JG
Molecules; 2014 Dec; 20(1):43-51. PubMed ID: 25546620
[TBL] [Abstract][Full Text] [Related]
30. Dual Parasiticidal Activities of Phthalimides: Synthesis and Biological Profile against Trypanosoma cruzi and Plasmodium falciparum.
Teixeira de Moraes Gomes PA; Veríssimo de Oliveira Cardoso M; Dos Santos IR; Amaro de Sousa F; da Conceição JM; Gouveia de Melo Silva V; Duarte D; Pereira R; Oliveira R; Nogueira F; Alves LC; Brayner FA; da Silva Santos AC; Rêgo Alves Pereira V; Lima Leite AC
ChemMedChem; 2020 Nov; 15(22):2164-2175. PubMed ID: 32813331
[TBL] [Abstract][Full Text] [Related]
31. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
Alvarez G; Aguirre-López B; Varela J; Cabrera M; Merlino A; López GV; Lavaggi ML; Porcal W; Di Maio R; González M; Cerecetto H; Cabrera N; Pérez-Montfort R; de Gómez-Puyou MT; Gómez-Puyou A
Eur J Med Chem; 2010 Dec; 45(12):5767-72. PubMed ID: 20889239
[TBL] [Abstract][Full Text] [Related]
32. Effect of a new anti-T. cruzi metallic compound based on palladium.
Mosquillo MF; Bilbao L; Hernández F; Machado I; Gambino D; Garat B; Pérez-Díaz L
Biometals; 2018 Dec; 31(6):961-974. PubMed ID: 30259247
[TBL] [Abstract][Full Text] [Related]
33. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.
Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC
Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146
[TBL] [Abstract][Full Text] [Related]
34. Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi.
Gomes PA; Oliveira AR; Cardoso MV; Santiago Ede F; Barbosa Mde O; de Siqueira LR; Moreira DR; Bastos TM; Brayner FA; Soares MB; Mendes AP; de Castro MC; Pereira VR; Leite AC
Eur J Med Chem; 2016 Mar; 111():46-57. PubMed ID: 26854377
[TBL] [Abstract][Full Text] [Related]
35. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
[TBL] [Abstract][Full Text] [Related]
36. 3-H-[1,2]Dithiole as a New Anti-Trypanosoma cruzi Chemotype: Biological and Mechanism of Action Studies.
Couto M; Sánchez C; Dávila B; Machín V; Varela J; Álvarez G; Cabrera M; Celano L; Aguirre-López B; Cabrera N; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Cerecetto H; González M
Molecules; 2015 Aug; 20(8):14595-610. PubMed ID: 26274947
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological characterization of new aryloxyindole-4,9-diones as potent trypanosomicidal agents.
Tapia RA; Salas CO; Vázquez K; Espinosa-Bustos C; Soto-Delgado J; Varela J; Birriel E; Cerecetto H; González M; Paulino M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3919-22. PubMed ID: 25008454
[TBL] [Abstract][Full Text] [Related]
38. Dehydrodieugenol B derivatives as antiparasitic agents: Synthesis and biological activity against Trypanosoma cruzi.
Ferreira DD; Sousa FS; Costa-Silva TA; Reimão JQ; Torrecilhas AC; Johns DM; Sear CE; Honorio KM; Lago JHG; Anderson EA; Tempone AG
Eur J Med Chem; 2019 Aug; 176():162-174. PubMed ID: 31103897
[TBL] [Abstract][Full Text] [Related]
39. Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies.
Palos I; Lara-Ramirez EE; Lopez-Cedillo JC; Garcia-Perez C; Kashif M; Bocanegra-Garcia V; Nogueda-Torres B; Rivera G
Molecules; 2017 Jun; 22(6):. PubMed ID: 28629155
[TBL] [Abstract][Full Text] [Related]
40. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.
Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV
PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
